Skip to content
Home
Dosage Forms
Oral Solid Dose
Semi-Solids
Liquids
Nasal Sprays
Ophthalmic
Sterile Injectables
Manufacturing & Packaging
Small Scale and Pilot
Scale-Up and Commercial
Packaging & Serialization
Development & Analytical Services
Formulation Development
Analytical Development
Analytical Testing
Stability Testing and Storage
Biologics
Cell Line & Process Development
Analytical & Formulation Development
Manufacturing
Quality Management
Project Management
Technologies
Handling Solvents
Modified Release
Extrusion Spheronization
Wurster Coating
Company News
Resources
About
Leadership Team
Why Choose Bora Pharmaceuticals
Quality
Culture
Sustainability
Locations
North America
Baltimore, MD
Maple Grove, MN
Mississauga, ON
Asia Locations
Tainan, Taiwan
Zhunan, Taiwan
Zhongli, Taiwan
Taoyuan, Taiwan
Zhubei, Taiwan
Careers at Bora
Accessibility
Contact Us
Stay Connected
Get the industry insights you care about. Join 3000+ subscribers and receive Bora resources and updates by email.
Resources
Bora expands its CMDO capabilities as it makes landmark acquisition of TWi Pharmaceuticals
Why it can take so long to validate pharmaceutical manufacturing processes during site-to-site technology transfers and what can be done to speed it up
Supply chain disruptions and their impact on quality and operations
Bora Pharmaceuticals acquires Eden Biologics CDMO Assets
The legacy of Mississauga’s leadership in Environment, Health and Safety
What is the best way to ensure a smooth technology transfer from one pharmaceutical manufacturing facility to another?
Previous
Next
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
